Investigating new cardiac biomarkers for diagnosing acute coronary syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify and evaluate new cardiac biomarkers and algorithms to improve the diagnosis of acute coronary syndrome (ACS) in patients suspected of having an acute myocardial infarction. It will assess various risk factors, including clinical, gender-specific, psychosocial, and lifestyle factors, alongside genetic variability and protein patterns. The study will also estimate the incidence of ACS in patients with recent chest pain and explore the impact of socioeconomic factors on cardiovascular risk. Participants will be followed during their hospital stay and through telephone follow-ups at specified intervals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Symptoms suggestive of acute myocardial infarction
* Ability to provide written informed consent in accordance with Good epidemiological Practice and local legislation
* Individuals at least 18 years old

Exclusion Criteria:

\- Insufficient knowledge of the German language (able to understand and write the German language)

Where it's running

• Department of Cardiology, University Heart Center Hamburg
  Hamburg, Germany Recruiting

Study contacts

• Principal investigator: Johannes Neumann, MD — Uhz
• Study coordinator: Johannes T Neumann, MD
• Email: j.neumann@uke.de
• Phone: 0049407410

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using magnetocardiography to identify heart attacks

  This study is testing if a new noninvasive heart scan method can help doctors better identify heart attacks in people with chest pain and healthy volunteers.

  Recruiting Qilu Hospital of Shandong University · Jinan, Shandong · NCT05896826

• ML-based diagnosis of blocked arteries in patients with a left bundle branch block

  Doctors are testing a machine learning tool that uses digital ECGs to see if a blocked coronary artery is present in patients with a left bundle branch block.

  Recruiting Konya City Hospital · Konya, Karatay · NCT07620119

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• AI-assisted interpretation of chest pain CT in the emergency department

  A pragmatic randomized trial tests whether an AI tool (Angiomics) helps emergency physicians interpret coronary CT angiography in adults with acute chest pain.

  Recruiting Yonsei University · Seoul · NCT07235657

• Understanding sex hormones and inflammation in heart disease

  This study looks at how sex hormones and inflammation affect heart disease in women to better understand their unique risks and improve treatment.

  Recruiting Queen Mary University of London · London · NCT06327984

• Effects of Dapagliflozin on Heart Health in Patients with Acute Coronary Syndromes

  This study is testing if dapagliflozin, a diabetes medication, can improve heart health in people who have just had a heart attack.

  Recruiting Phase 2/3 University of Sao Paulo · São Paulo, São Paulo · NCT06286878

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.